Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | ROBO Global Healthcare Technology and Innovation |
| Investment focus | Aandelen, Wereld, Gezondheidszorg |
| Fund size | EUR 173 m |
| Total expense ratio | 0,49% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 18,71% |
| Inception/ Listing Date | 2 juli 2019 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ierland |
| Fund Provider | Legal & General (LGIM) |
| Fund Structure | Public Limited Company |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | Legal & General Investment Management Limited |
| Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
| Revision Company | Ernst & Young |
| Fiscal Year End | 30 juni |
| Swiss representative | State Street Bank International GmbH, Munich, Zurich Branch |
| Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
| Germany | 30% belastingvermindering |
| Switzerland | ESTV Reporting |
| Austria | Belastingrapportagefonds |
| UK | UK-rapportage |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | BNY Mellon Fund Services (Ireland) Limited |
| Securities lending | No |
| Securities lending counterparty |
| AxoGen | 2,38% |
| Alnylam Pharmaceuticals | 2,16% |
| Arrowhead Pharmaceuticals | 2,14% |
| Vertex Pharmaceuticals | 2,09% |
| Natera | 2,09% |
| Boston Scientific Corp. | 2,07% |
| Thermo Fisher Scientific | 2,05% |
| Guardant Health, Inc. | 2,04% |
| Intuitive Surgical | 2,02% |
| LivaNova | 1,98% |
| Verenigde Staten | 72,62% |
| Zwitserland | 3,49% |
| Verenigd Koninkrijk | 3,14% |
| Duitsland | 1,85% |
| Anders | 18,90% |
| Gezondheidszorg | 86,93% |
| Consumer Discretionary | 2,78% |
| Technologie | 1,54% |
| Anders | 8,75% |
| YTD | -2.38% |
| 1 month | +3.09% |
| 3 months | -3.07% |
| 6 months | -4.93% |
| 1 year | +23.42% |
| 3 years | +11.18% |
| 5 years | -17.80% |
| Since inception (MAX) | +41.40% |
| 2025 | +9.92% |
| 2024 | +9.53% |
| 2023 | -6.26% |
| 2022 | -29.18% |
| Volatility 1 year | 18.71% |
| Volatility 3 years | 38.09% |
| Volatility 5 years | 34.15% |
| Return per risk 1 year | 1.41 |
| Return per risk 3 years | 0.10 |
| Return per risk 5 years | -0.11 |
| Maximum drawdown 1 year | -15.45% |
| Maximum drawdown 3 years | -40.47% |
| Maximum drawdown 5 years | -50.52% |
| Maximum drawdown since inception | -50.89% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XMLH | - - | - - | - |
| Borsa Italiana | EUR | DOCT | DOCT IM DOCEURIV | LGDOCT.MI DOCTEURINAV=SOLA | Flow Traders B.V. |
| London Stock Exchange | GBX | DOCG | DOCG LN NA | DOCG.L NA | Flow Traders B.V. |
| London Stock Exchange | USD | DOCT | DOCT LN NA | DOCT.L NA | Flow Traders B.V. |
| SIX Swiss Exchange | CHF | DOCT | DOCT SW DOCEURIV | DOCT.S | Flow Traders B.V. |
| Xetra | EUR | XMLH | XMLH GY DOCEURIV | DOCT.DE | Flow Traders B.V. |